We are live on ! Find out more
WBWA

William B. Walkup & Associates Portfolio holdings

AUM $208M
1-Year Est. Return 37.34%
This Fund
S&P 500
This Quarter Est. Return
+0.13%
1 Year Est. Return
+37.34%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$183M
AUM Growth
-$4M
Cap. Flow
-$1.13M
Cap. Flow %
-0.62%
Top 10 Hldgs %
48.28%
Holding
170
New
7
Increased
27
Reduced
49
Closed
3

Top Buys

Rank Stock Value
1
Q
Qnity Electronics Inc
Q
+$307K
2
WU icon
Western Union
WU
+$198K
3
HCA icon
HCA Healthcare
HCA
+$114K
4
FMC icon
FMC
FMC
+$46.8K
5
CI icon
Cigna
CI
+$45.4K

Top Sells

Rank Stock Value
1
DD icon
DuPont de Nemours
DD
+$400K
2
ABBV icon
AbbVie
ABBV
+$128K
3
JPM icon
JPMorgan Chase
JPM
+$128K
4
EMN icon
Eastman Chemical
EMN
+$109K
5
WMT icon
Walmart Inc
WMT
+$99.4K

Sector Composition

Rank Sector Weight
1 Financials 23.36%
2 Consumer Discretionary 20.04%
3 Healthcare 17.31%
4 Energy 13.29%
5 Industrials 7.6%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AZO icon
1
AutoZone
AZO
$49.2B
$21.1M 11.56%
6,226
-21
-0.3% -$79.3K
VLO icon
2
Valero Energy
VLO
$90.1B
$12.3M 6.71%
75,284
-324
-0.4% -$54.9K
COF icon
3
Capital One
COF
$128B
$10.1M 5.55%
41,803
-345
-0.8% -$76.8K
JPM icon
4
JPMorgan Chase
JPM
$935B
$9.71M 5.32%
30,147
-412
-1% -$128K
WMT icon
5
Walmart Inc
WMT
$885B
$8.12M 4.44%
72,870
-926
-1% -$99.4K
HD icon
6
Home Depot
HD
$331B
$6.72M 3.68%
19,535
-161
-0.8% -$59K
ABBV icon
7
AbbVie
ABBV
$443B
$5.85M 3.2%
25,605
-560
-2% -$128K
MCK icon
8
McKesson
MCK
$100B
$5.46M 2.99%
6,655
-85
-1% -$69.4K
ALL icon
9
Allstate
ALL
$68B
$5.05M 2.76%
24,246
-396
-2% -$81.1K
NOC icon
10
Northrop Grumman
NOC
$77.1B
$3.78M 2.07%
6,636
-40
-0.6% -$23.2K
MS icon
11
Morgan Stanley
MS
$331B
$3.77M 2.06%
21,228
-379
-2% -$63.2K
TRV icon
12
Travelers Companies
TRV
$78.1B
$3.75M 2.05%
12,921
-213
-2% -$59.9K
KMI icon
13
Kinder Morgan
KMI
$71.7B
$3.57M 1.95%
129,852
-385
-0.3% -$10.4K
NUE icon
14
Nucor
NUE
$58.6B
$3.46M 1.9%
21,225
-232
-1% -$34.9K
UNH icon
15
UnitedHealth
UNH
$376B
$3.41M 1.87%
10,321
-64
-0.6% -$21.7K
MRK icon
16
Merck
MRK
$322B
$2.85M 1.56%
27,091
+38
+0.1% +$3.57K
EMN icon
17
Eastman Chemical
EMN
$8B
$2.69M 1.47%
42,163
-1,763
-4% -$109K
INTC icon
18
Intel
INTC
$455B
$2.64M 1.45%
71,661
-878
-1% -$33.2K
JNJ icon
19
Johnson & Johnson
JNJ
$618B
$2.56M 1.4%
12,366
-479
-4% -$94.7K
LLY icon
20
Eli Lilly
LLY
$1.02T
$2.48M 1.36%
2,307
LOW icon
21
Lowe's Companies
LOW
$117B
$2.47M 1.35%
10,225
-163
-2% -$39.1K
LH icon
22
Labcorp
LH
$25B
$2.42M 1.32%
9,646
-6
-0.1% -$1.59K
DHI icon
23
D.R. Horton
DHI
$40B
$2.41M 1.32%
16,742
-563
-3% -$85.7K
VZ icon
24
Verizon
VZ
$195B
$2.19M 1.2%
53,766
-1,347
-2% -$54.6K
COP icon
25
ConocoPhillips
COP
$147B
$2.13M 1.17%
22,753
-326
-1% -$29.5K

Similar funds

William B. Walkup & Associates's Q4 2025 Portfolio in Review

As of Q4 2025, William B. Walkup & Associates held 170 positions worth $183M, down 2.1% from $187M the previous quarter. Its ten largest holdings account for 48% of the portfolio.

William B. Walkup & Associates's Q4 2025 filing shows 7 new, 27 increased, 49 reduced and 3 closed positions. Its largest new stake was Qnity Electronics Inc: 3,614 shares worth $295K. The largest sale was DuPont de Nemours, an estimated $400K.

By sector, the portfolio is most concentrated in Financials at 23% of assets, up from 22% a quarter earlier, followed by Consumer Discretionary and Healthcare.

  • William B. Walkup & Associates's largest Q4 2025 buy was Qnity Electronics Inc: 3,614 shares worth $295K.
  • William B. Walkup & Associates added most to Western Union in Q4 2025, an estimated $198K increase.
  • William B. Walkup & Associates's biggest Q4 2025 reduction was DuPont de Nemours, cutting an estimated $400K.
  • William B. Walkup & Associates fully exited ZimVie in Q4 2025, selling an estimated $5.51K.
  • William B. Walkup & Associates's ten largest holdings make up 48% of its $183M portfolio in Q4 2025.
  • William B. Walkup & Associates opened 7 new positions and closed 3 in Q4 2025.
  • William B. Walkup & Associates's portfolio value fell 2.1% quarter-over-quarter to $183M.

Based on William B. Walkup & Associates's 13F filing for Q4 2025, filed 17 Feb 2026.